跳至主要内容
临床试验/CTRI/2022/02/040402
CTRI/2022/02/040402已完成3 期

Comparison of oral tamoxifen. versus centchromon in reducing the size of breast fibroadenoma in adolescent and middle aged ladies

All India Institute of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • FNAC proven breast fibroadenoma of size < 5 cm

排除标准

  • 1. Past history of carcinoma breast
  • 2. Family history of carcinoma breast in 1st degree relatives
  • 3. History of PCOD, cervical dysplasia, and liver disease
  • 4. Pregnancy and Lactating ladies
  • 5. Recurrent fibroadenoma
  • 6. Fibroadenoma associated with cellular atypic
  • 7. Ladies planning pregnancy during the study period
  • 8. BMI >35 kg/m2
  • 9. Baseline endometrial thickness > 12 mm

研究者

相似试验